1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. DESIGN THERAPEUTICS INC
Design Therapeutics Inc XNAS: DSGN

Design Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modify...

Read More
3.87 -0.16 (-3.97%)
50.19% Fall from 52W High
162.3K
XNAS Volume

XNAS 31 Jul, 2025 4:01 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Design Therapeutics Inc is on 05 Aug 2025 for the purpose of Design Therapeutics Inc Second Quarter Earnings Results for 2025 See details
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
12.3 / 100
Momentum Score
Technically Neutral
41.5 / 100
Analyst Price Target
No estimates available

10

S

10

W

0

O

3

T

SWOT Analysis

Design Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..